Clinical trial
Effect of rFVIIa on Peri-operative Blood Loss in Patients Undergoing Major Burn
NCT00243243 · United States Army Institute of Surgical Research, U.S. Fed · Completed
Key facts
| NCT number | NCT00243243 |
|---|---|
| Title | Effect of rFVIIa on Peri-operative Blood Loss in Patients Undergoing Major Burn |
| Official title | Effect of Recombinant Coagulation Factor VIIa on Peri-operative Blood Loss in Patients Undergoing Major Burn Excision and Grafting |
| Lead sponsor | United States Army Institute of Surgical Research, U.S. Fed |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Burns |
| Intervention type | Drug |
| Interventions | Recombinant Factor VIIa, Placebo |
| Enrollment | 20 |
| Start date | Jan 1, 2006 |
| Primary completion | Jun 1, 2011 |
| Completion | Jul 1, 2011 |
| First posted | Oct 21, 2005 |
| Last update posted | May 26, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: